Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement resistance mechanisms of streptococci.

Hanna Jarva1, T Sakari Jokiranta, Reinhard Würzner

  • 1Department of Bacteriology and Immunology, Haartman Institute and HD-Diagnostics, University of Helsinki and Helsinki University Central Hospital, Haartmaninkatu 3, P.O. Box 21, FIN-00290 Helsinki, Finland.

Molecular Immunology
|August 14, 2003
PubMed
Summary

Group A Streptococcus, Group B Streptococcus, and pneumococcus evade immune defenses using complement resistance mechanisms. Understanding these bacterial evasion strategies is crucial for developing effective vaccines against these significant human pathogens.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differential distribution of HLA-A, HLA-B, and HLA-DRB1 allele groups in Iranian pediatric and adult patients with acute lymphoblastic Leukemia: A Case-Control study.

Human immunology·2026
Same author

A prospective evaluation of Cepheid Xpert® and Roche cobas® HIV-1, HBV and HCV assays for nucleic acid quantification.

Diagnostic microbiology and infectious disease·2026
Same author

Homozygous C1qA Deficiency Presenting as Early-Onset Systemic Lupus Erythematosus: A Case Report With a Literature Review.

Case reports in immunology·2026
Same author

Interactions of dual antiplatelet and anticoagulant with C1q and FH regulate complement activation by injured cells.

Blood vessels, thrombosis & hemostasis·2026
Same author

Risk Haplotype of BTNL2 Predisposes Male Patients to NSTEMI: A Genetic and Functional Study.

Research square·2026
Same author

Baseline malaria burden and pyrethroid resistance in Muheza, Tanzania informing a cluster randomized trial of the 3D window screens.

Scientific reports·2026

Area of Science:

  • Microbiology
  • Immunology
  • Pathogenesis

Background:

  • Group A Streptococcus (GAS), Group B Streptococcus (GBS), and Streptococcus pneumoniae are major human pathogens causing substantial global morbidity and mortality.
  • These bacteria cause diverse infections, from superficial to severe systemic diseases, necessitating survival strategies against host defenses.
  • The complement system is a critical arm of innate immunity, involved in pathogen clearance and antibody effector functions.

Purpose of the Study:

  • To review and describe the complement resistance mechanisms employed by GAS, GBS, and S. pneumoniae.
  • To highlight the analogous yet distinct strategies these three key streptococcal species use to evade complement-mediated immunity.
  • To underscore the importance of studying these mechanisms for vaccine development.

Related Experiment Videos

Main Methods:

  • Review of existing literature on streptococcal complement evasion.
  • Analysis of molecular mechanisms used by GAS, GBS, and S. pneumoniae to resist complement.
  • Comparative examination of complement resistance strategies across the three species.

Main Results:

  • GAS, GBS, and S. pneumoniae utilize analogous but distinct mechanisms to resist complement.
  • Several strains express surface molecules (e.g., M-proteins, Bac, PspC) that bind host complement regulators (Factor H, C4b-binding protein).
  • GAS and GBS also secrete proteins/enzymes that inhibit complement activation and chemotaxis.

Conclusions:

  • Despite known mechanisms, streptococcal infections remain a significant health burden, emphasizing the need for further research.
  • Identifying and understanding streptococcal molecules involved in complement resistance is vital for developing novel vaccines.
  • Continued investigation into bacterial immune evasion is essential for combating infectious diseases caused by these pathogens.